Gameto https://validator.w3.org/feed/docs/rss2.html Home-Draft-FertiloSections Gameto lands $44m to advance fertility and menopause programs Home Gameto to Showcase Innovative Therapies at ASRM 2025: Advancing Menopause Treatment and Embryology Solutions Gameto Selected for Seven Presentations at the American Society for Reproductive Medicine (ASRM) 2024 Annual Meeting Gameto Appoints Dr. Jaime Knopman as Chairwoman of Clinical Advisory Board to Guide Clinical Strategy and Innovation in Women’s Health Gameto Appoints Dr. Ghassan (Gus) Haddad as Chief Medical Officer to Lead Clinical Development of Fertilo, a Cell-Based Treatment for IVF and Egg Freezing Gameto CEO Dr. Dina Turner Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit Gameto Unveils New Data on In Vitro Maturation Product Candidate Fertilo During Four Presentations at the 2023 American Society for Reproductive Medicine Gameto Presents Data Supporting Manufacturing Process for its In Vitro Maturation Solution for Fertility Care at 2024 International Society for Stem Cell Research Annual Meeting REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs Gameto Named as 2023 Technology Pioneer by World Economic Forum Gameto Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health Gameto Expands Executive Team with the Addition of Teri Loxam as Chief Financial Officer Fertilo Updates Interested in Working at Gameto? Medical Director Introducing BioSpace’s 2025 40 Under 40 Winners: Dr. Dina Radenkovic Register Interest in Fertilo A company is trying to unlock a key to aging, in a long-overlooked body part ‘People Thought It Was Insane’: How Startup Gameto Is Turning Women’s Health Sci-Fi Into Reality In Conversation with Dina Radenkovic Turner, Gameto’s CEO and Co-Founder Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors The quest to make babies with lab-grown eggs and sperm Vice President of Accounting Careers Associate, CEO Office Company Gameto Licenses Foundational Meiosis IP to Advance Human Ovary-in-a-Dish Platform Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference Fertilo Gameto’s $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial New IVF protocol offered in Texas provides hope to families MIT Technology Review Innovators Under 35: Christian Kramme, PhD ABJ Women in Business Awards 2025: Dr. Dina Radenkovic Dr. Dina Radenkovic takes us to the future I’m the first woman in Australia to become pregnant this way Gameto Raises $44 Million for Stem Cell IVF Therapy IVF Reborn: Engineered Ovarian Cells for Maturing Eggs Reach Final Test A Sydney woman is the first in Australia to fall pregnant using a new ‘gentler’ IVF technique. For Clinics Is Fertilo Available in My Country Development of human induced pluripotent stem cell-derived ovarian support cells as a clinical-grade product for in vitro fertilization Fertility startup Gameto raises $44M to fund Phase 3 study of stem cell IVF therapy Gameto Raises $44M Series C as Stem Cell IVF Therapy Enters Phase 3 Trial Fertility Startup Gameto Raises $44M to Test Egg-Freezing Therapy in US Pipeline For Women and Families New cheaper and less gruelling IVF technique being trialled in Sydney Ameno